These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 17409422)
21. A novel human cell culture model for the study of familial prostate cancer. Yasunaga Y; Nakamura K; Ewing CM; Isaacs WB; Hukku B; Rhim JS Cancer Res; 2001 Aug; 61(16):5969-73. PubMed ID: 11507036 [TBL] [Abstract][Full Text] [Related]
22. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population. Heer R; Robson CN; Shenton BK; Leung HY J Cell Physiol; 2007 Sep; 212(3):572-8. PubMed ID: 17541959 [TBL] [Abstract][Full Text] [Related]
23. Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Litvinov IV; Vander Griend DJ; Xu Y; Antony L; Dalrymple SL; Isaacs JT Cancer Res; 2006 Sep; 66(17):8598-607. PubMed ID: 16951173 [TBL] [Abstract][Full Text] [Related]
24. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148 [TBL] [Abstract][Full Text] [Related]
25. Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+CD44+ prostate cancer stem cells. Rentala S; Chintala R; Guda M; Chintala M; Komarraju AL; Mangamoori LN Biochem Biophys Res Commun; 2013 Nov; 441(3):586-92. PubMed ID: 24177008 [TBL] [Abstract][Full Text] [Related]
26. Expression analysis of putative stem cell markers in human benign and malignant prostate. Ugolkov AV; Eisengart LJ; Luan C; Yang XJ Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131 [TBL] [Abstract][Full Text] [Related]
27. A novel neoplastic primary tumor-derived human prostate epithelial cell line. Ko D; Gu Y; Yasunaga Y; Nakamura K; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Arnstein P; Taylor DO; Hukku B; Rhim JS Int J Oncol; 2003 Jun; 22(6):1311-7. PubMed ID: 12738999 [TBL] [Abstract][Full Text] [Related]
28. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. Taylor RA; Toivanen R; Frydenberg M; Pedersen J; Harewood L; ; Collins AT; Maitland NJ; Risbridger GP Stem Cells; 2012 Jun; 30(6):1087-96. PubMed ID: 22593016 [TBL] [Abstract][Full Text] [Related]
29. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma. Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504 [TBL] [Abstract][Full Text] [Related]
30. CD133, one of the markers of cancer stem cells in Hep-2 cell line. Zhou L; Wei X; Cheng L; Tian J; Jiang JJ Laryngoscope; 2007 Mar; 117(3):455-60. PubMed ID: 17334305 [TBL] [Abstract][Full Text] [Related]
31. Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach. Xing Y; Liu M; Du Y; Qu F; Li Y; Zhang Q; Xiao Y; Zhao J; Zeng F; Xiao C Cancer Biol Ther; 2008 Nov; 7(11):1839-48. PubMed ID: 18836306 [TBL] [Abstract][Full Text] [Related]
32. Analyzing migratory properties of human CD133(+) stem cells in vivo after intraoperative sternal bone marrow isolation. Donndorf P; Useini D; Lux CA; Vollmar B; Delyagina E; Laupheimer M; Kaminski A; Steinhoff G Cell Transplant; 2013; 22(9):1627-35. PubMed ID: 23051098 [TBL] [Abstract][Full Text] [Related]
33. Progenitor cells are responsible for formation primary epithelial cultures in the prostate epithelial model. Drewa T; Styczynski J Int Urol Nephrol; 2007; 39(3):851-7. PubMed ID: 17318344 [TBL] [Abstract][Full Text] [Related]
34. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Wei C; Guomin W; Yujun L; Ruizhe Q Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251 [TBL] [Abstract][Full Text] [Related]
35. Expression of CD133 and other putative stem cell markers in uveal melanoma. Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792 [TBL] [Abstract][Full Text] [Related]
36. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling. Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449 [TBL] [Abstract][Full Text] [Related]
37. Preferential interaction of platelets with prostate cancer cells with stem cell markers. Rudzinski JK; Govindasamy NP; Asgari A; Saito MS; Lewis JD; Jurasz P Thromb Res; 2021 Oct; 206():42-51. PubMed ID: 34403851 [TBL] [Abstract][Full Text] [Related]
38. Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancer. Wang N; Docherty F; Brown HK; Reeves K; Fowles A; Lawson M; Ottewell PD; Holen I; Croucher PI; Eaton CL FASEB J; 2015 Aug; 29(8):3141-50. PubMed ID: 25888599 [TBL] [Abstract][Full Text] [Related]
39. Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Fan X; Liu S; Su F; Pan Q; Lin T Urol Oncol; 2012; 30(3):314-8. PubMed ID: 20843707 [TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]